Annual Drug Patent Expirations for PRISTIQ
Pristiq is a drug marketed by Pf Prism Cv and is included in one NDA. It is available from four suppliers. There are two patents protecting this drug and two Paragraph IV challenges.
Drug patent litigation for PRISTIQ.
This drug has sixty-three patent family members in thirty-two countries.
The generic ingredient in PRISTIQ is desvenlafaxine succinate. Four suppliers are listed for this compound. Additional details are available on the desvenlafaxine succinate profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com
